Progesterone Sensitizes Ovarian Cancer Cells to Paclitaxel by Reshaping Microtubule Chemistry
New laboratory research shows progesterone increases vasohibin-2 expression and tubulin detyrosination in progesterone receptor-negative ovarian cancer cells, sharply boosting their ...
